Lettre addictovigilance n°3 - mars 2011

!
!
La Lettre d’addictovigilance – n°3, mars 2011 ! !
!
"#$%&'(')&! *'! +$! *,-+'-#!.! $&&')&%,)! /! +0$**%1&%,)2! 3$#&%1-+%4#'(')&! $5'1! +'!
6')&$)7+!8!
"#!$%#&'!()'!()&*+)&'!,%+'-!./#'+)#&'!$0'!.0&1+$#/+2&),)*1!3&04)'!()!(5.)*(0*$)!04)$!()'!,5(+$0,)*1'!
%.+0$5'!*%#'!%*1!515!'+3*0/5'-!'%+1!(0*'!()'!+*(+$01+%*'!6%&'!"77-!'%+1!(0*'!()'!+*(+$01+%*'!%88+$+)//)'!,0+'!
'0*'!0$$%,.03*),)*1!(#!,0/0()!.%#&!/0!8+*!()!1&0+1),)*19!:0!$%,.#/'+%*!()4+)*1!&0.+(),)*1!+,.%&10*1)-!
/0! &)$6)&$6)! (;)88)1'! .%'+1+8'! )1! )#.6%&+'0*1'! )'1! #*)! $%*'10*1)-! 0/%&'! ,<,)! =#)! /)'! (%#/)#&'! +*+1+0/),)*1!
1&0+15)'! %*1! .0&8%+'! (+'.0&#9! >0*'! /)'! $0'! *%1+8+5'-! +/! ';03+''0+1! ()! .&)'$&+.1+%*! .%#&! (%#/)#&'! *%*!
$0*$5&)#')'!?! (%#/)#&'! .%'1@%.5&01%+&)'-! .%/A1&0#,01+',)-! /%,B0/3+)'! $6&%*+=#)'! 04)$! %#! '0*'! 6)&*+)!
(+'$0/)-!'A*(&%,)!()'!C0,B)'!'0*'!&).%'-!)1$9!)1!/)'!,5(+$0,)*1'!)*!$0#')!510+)*1!.&+*$+.0/),)*1!/)!8)*10*A/!
D'.5$+0/+15'!(;0$1+%*!+,,5(+01)E-!,0+'!0#''+!/;%FA$%(%*)!)1!/)!1&0,0(%/!
G%*1&0+&),)*1!H!#*)!+(5)!1&2'!&5.0*(#)-!/)!&+'=#)!()!(5.)*(0*$)!(0*'!/)!1&0+1),)*1!()!/0!(%#/)#&!*;)'1!
.0'!*#/-!*%10,,)*1!(0*'!#*!$%*1)F1)!()!4#/*5&0B+/+15!1)/!=#;#*!1&0#,01+',)!.'A$6+=#)!%#!#*!'A*(&%,)!()!
'1&)''!.%'1@1&0#,01+=#)9!:)'!%.+0$5'!*)!'%*1!.0'!8%&$5,)*1!/0!B%**)!&5.%*')!165&0.)#1+=#)!.%#&!1%#1)'!/)'!
(%#/)#&'! $6&%*+=#)'! *%*! $0*$5&)#')'9! :0! '1&0153+)! (;#1+/+'01+%*! ()'! 0*10/3+=#)'! 04)$! /)'! .0/+)&'! ()! /;I7J!
.%#&! /)'! (%#/)#&'! $0*$5&)#')'! *)! ';0../+=#)! .0'! 8%&$5,)*1! H! 1%#1)'! /)'! (%#/)#&'! $6&%*+=#)'! *%*!
$0*$5&)#')'9! K%#&! /)! 'A*(&%,)! ()! '1&)''! .%'1@1&0#,01+=#)-! /0! L0#1)! "#1%&+15! ()! J0*15! &)$%**0M1! /;+*15&<1!
.%1)*1+)/! ()! /0! .'A$6%165&0.+)! $%3*+1+4%@$%,.%&1),)*10/)! DNGGE! )1! ()! /;O7>P! DEye$ Movement$
Desensitization$ and$ ReprocessingE9! Q*! 1&0+1),)*1! .'A$6%165&0.+=#)! .)#1! <1&)! )*4+'035! (0*'! $)&10+*)'!
(%#/)#&'!$6&%*+=#)'!*%*!$0*$5&)#')'!040*1!()!.&)'$&+&)!()'!%.+0$5'!=#+!.)#4)*1!1&2'!4+1)!,)11&)!/)!,0/0()!
(0*'!#*)!'.+&0/)!'0*'!8+*9!!
:)! 8)*10*A/! )'1! .0&1+$#/+2&),)*1! H! &+'=#)! .#+'=#)! $;)'1! /;%.+0$5! /)! ./#'! .#+''0*1! (+'.%*+B/)! .%#&! /)!
1&0+1),)*1!()!/0!(%#/)#&-!,0+'!1%#'!/)'!%.+0$5'!.)#4)*1!<1&)!)*!$0#')!D1&0,0(%/-!%FA$%(%*)-!'0*'!%#B/+)&!/)'!
0''%$+01+%*'!8+F)'!04)$!(#!.0&0$510,%/-!.0&1+$#/+2&),)*1!+//%3+=#)'!$0&!0''%$+0*1!()'!0*10/3+=#)'!()!(#&5)'!
(;0$1+%*!(+885&)*1)'!'0*'!.%#4%+&!C%#)&!'#&!/;0(0.101+%*!.%'%/%3+=#)!()!$60=#)!0*10/3+=#)E9!!
R%+$+!#*!&0..)/!()!=#)/=#)'!&23/)'!5/5,)*10+&)'!()!.&)'$&+.1+%*!()!8)*10*A/!D4%+&!/)'!,%*%3&0.6+)'!()'!
(+885&)*1)'!'.5$+0/+15'!.%#&!#*)!+*8%&,01+%*!$%,./21)E9!
:)!8)*10*A/!(%+1!<1&)!.&)'$&+1!(0*'!#*!$0(&)!()!1&0+1),)*1!+*153&5!()!/0!(%#/)#&-!04)$!540/#01+%*!,5(+$0/)-!
'%$+0/)!)1!.'A$6%/%3+=#)9!
S)!C0,0+'!%#B/+)&!=#)!/)!8)*10*A/!)'1!)*4+&%*!TUU!8%+'!./#'!.#+''0*1!=#)!/0!,%&.6+*)9!
9114:! *,-+,-#'-;! 3$#,;7:&%<-'! *0,#%=%)'! 1$)1>#'-:'2! ')! 1,(3+>(')&! *0-)! &#$%&'(')&! ,3%$1>! *'! 6,)*!
:&$?%+%:>!!
@A!B')&$)7+2!6,#(':!*0$1&%,)!%((>*%$&'C!Ces$formes$n’ont$aucune$autre$indication.!
Les$points$importants$$
@!C0,0+'!.%#&!()'!(%#/)#&'!*%*!$0*$5&)#')'!V!C0,0+'!'0*'!1&0+1),)*1!%.+0$5!()!8%*(!$%&&)$1),)*1!5=#+/+B&5!
Principales$caractéristiques$$$
@!&+'=#)!,0C)#&! ()! (5.&)''+%*!&)'.+&01%+&)!V!&+'=#)!,0C)#&! (;+*1%F+$01+%*!0$$+()*1)//)! $6)W!/;)*80*1!V! &+'=#)!
,0C)#&! ()! (5.)*(0*$)!?! (5/0+! (;0$1+%*! 1&2'! &0.+()-! (#&5)! (;0$1+%*! $%#&1)-! 8%&,)'! .60&,0$)#1+=#)'!
X!B0*0/+'5)'!Y!
Spécialités$disponibles$
8%&,)'!(;0$1+%*!+,,5(+01)!
!
J.5$+0/+15'!
Z%&,)!
>%'03)'!
"B'1&0/[!
$%,.&+,5!'#B/+*3#0/!
TUU-!\UU-!]UU-!^UU-!_UU-!`UU!µ3!
"$1+=[!
$%,.&+,5!04)$!0../+$01)#&!B#$$0/!DX!'#$)11)!YE!
\UU-!^UU-!_UU-!`UU-!T\UU-!T_UU!µ3!
O88)*1%&0[!
$%,.&+,5!3+*3+40/!
TUU-!\UU-!^UU-!_UU-!`UU!µ3!
a*'10*A/[!
'%/#1+%*!.%#&!.#/45&+'01+%*!*0'0/)!
bU-!TUU-!\UU!µ3!
Attention$:$ces$spécialités$ne$sont$pas$interchangeables$(voir$monographies)$

!
!
Posologie$et$mode$d’emploi$$
:0! ,+')! )*! &%#1)! (#! 1&0+1),)*1! (%+1! 1%#C%#&'! <1&)! 80+1)! )*! #1+/+'0*1! /)! ./#'! 80+B/)! (%'03)9! J)! &585&)&! 0#F!
,%(0/+15'!.&5$+')'!.%#&!$60=#)!'.5$+0/+159!
Interactions$!
@!:)!8)*10*A/!)'1!,510B%/+'5!.0&!/;+'%)*WA,)!]"^!(#!$A1%$6&%,)!K^bU!?!!
c!/)'!+*(#$1)#&'!)*WA,01+=#)'!(#!GdK]"^!(+,+*#)*1!/0!B+%(+'.%*+B+/+15!(#!8)*10*A/!)1!(%*$!'%*!)88)1!
0*10/3+=#)!?! 0*1+$%*4#/'+40*1'! +*(#$1)#&'! )*WA,01+=#)'! D$0&B0,0W5.+*)-! 8%'.65*A1%+*)-! .65*%B0&B+10/-!
.65*A1%+*)-!.&+,+(%*)E-!&+80,.+$+*)!!?!0''%$+01+%*!(5$%*')+//5)!!
c! /)'! +*6+B+1)#&'! )*WA,01+=#)'! (#! GdK]"^! .)#4)*1!0#3,)*1)&! /0!B+%(+'.%*+B+/+15! (#! 8)*10*A/-!04)$!
#*! &+'=#)! ()! '#&(%'03)! %#! ()! .&%/%*301+%*! (;)88)1!?! $)&10+*'! ,0$&%/+()'! D$/0&+16&%,A$+*)-! 5&A16&%,A$+*)-!
15/+16&%,A$+*)E-! 0*1+8%*3+=#)'! +,+(0W%/5'! De51%$%*0W%/)-! +1&0$%*0W%/)-! 4%&+$%*0W%/)-! .%'0$%*0W%/)E-!
0*1+.&%150')'! D&+1%*04+&-! *)/8+*04+&E-! C#'! ()! .0,./),%#'')9! G)'! +*1)&0$1+%*'! ()4&0+)*1! <1&)! ,)*1+%**5)'!
.&%$60+*),)*1! (0*'! /)! 16)'0#&#'! ()'! +*1)&0$1+%*'! ()! /;"8''0.'!D)//)'! 8+3#&)*1! (0*'! /)'! ,%*%3&0.6+)'! ()'!
(+885&)*1)'!'.5$+0/+15'E!
@! /)'! 03%*+'1)'@0*103%*+'1)'! ,%&.6+*+=#)'!.)#4)*1! )*1&0+*)&! #*)! (+,+*#1+%*! ()! /;)88)1! 0*10/3+=#)! )1! #*!
'A*(&%,)!()!')4&03)!?!$%*1&)@+*(+$01+%*!!
@! ,5(+$0,)*1'! (5.&)'')#&'! (#! 'A'12,)! *)&4)#F! $)*1&0/! D*%10,,)*1! B)*W%(+0W5.+*)'-! B0&B+1#&+=#)'-!
0*1+6+'10,+*+=#)'!'5(01+8'-!,5.&%B0,01)-!)1$9E-!0/$%%/!?!0''%$+01+%*!H!.&)*(&)!)*!$%,.1)!
Réglementation$$$
:+'1)!()'!'1#.58+0*1'-!.&)'$&+.1+%*!/+,+15)!H!\`!C%#&'!D'#&!%&(%**0*$)!'5$#&+'5)E-!(5/+4&0*$)!8&0$1+%**5)!H!f!
C%#&'!
D,-+'-#:!1E#,)%<-':!:>54#':2!)'!3,-5$)&!F&#'!&#$%&>':!<-'!3$#!*':!$)&$+=%<-':!,3%$1>:!
@A!B')&$)7+2!6,#('!*0$1&%,)!3#,+,)=>'!GpatchH!
/%*3#)!(#&5)!(;0$1+%*!Df\!6E!!
Les$points$importants$
@!B0*0/+'01+%*!(#!patch!D%88+$+)//),)*1!X!(+'.%'+1+8!1&0*'()&,+=#)!YE-!.0&8%+'!0''+,+/5!H!#*)!8%&,)!1%.+=#)!g!V!
*)! .0'!$%,,)*$)&!#*!1&0+1),)*1! .0&!patch!()!8)*10*A/! ,0+'! 5=#+/+B&)&!(;0B%&(! 04)$!()!/0!,%&.6+*)! D4%+&!
)*'#+1)!,%*%3&0.6+)!.%#&!5=#+40/)*$)'!()!.%'%/%3+)E!V!*)!.0'!(5$%#.)&!/)!patch!V!.&#()*$)!)*!$0'!()!8+24&)!
D0#3,)*101+%*!()!/;0B'%&.1+%*E!V!)*/)4)&!/)!.01$6!.&5$5()*1!/%&'!()!/0!.%')!(;#*!*%#4)0#!patch!D()'!,0/0()'!
h35'! '%*1!.0&8%+'! 6%'.+10/+'5'!)*!&50*+,01+%*! .%#&! $%,0! )1! %*1! ./#'+)#&'! patches! '#&! (+885&)*1)'! W%*)'! (#!
$%&.'!gE!
Principales$caractéristiques$:$$
@!.)#1!<1&)!#1+/+'5!$6)W!/;)*80*1!H!.0&1+&!()!\!0*'!D!gE!V!.)#1!<1&)!#1+/+'5!)*!$0'!()!(A'.603+)!V!&+'=#)!,0C)#&!()!
(5.&)''+%*! &)'.+&01%+&)!V! &+'=#)! ,0C)#&! (;+*1%F+$01+%*! 0$$+()*1)//)! $6)W! /;)*80*1!V! &+'=#)! ,0C)#&! ()!
(5.)*(0*$)!
Spécialités$disponibles$
>#&%35'+$[-!(%'03)'!H!T\!µ3i6-!\b!µ3i6-!bU!µ3i6-!fbµ3i6-!TUUµ3i6!)1!35*5&+=#)'!!
Posologie$et$mode$d’emploi$$
R%+&!supra!
Interactions$$
R%+&!supra!
Réglementation$$$
:+'1)!()'!'1#.58+0*1'-!.&)'$&+.1+%*!/+,+15)!H!\`!C%#&'!D'#&!%&(%**0*$)!'5$#&+'5)E-!(5/+4&0*$)!8&0$1+%**5)!H!T^!
C%#&'!
Remboursement$
Non$remboursable$dans$les$douleurs$non$cancéreuses.$$
:)! &),B%#&'),)*1! )'1! &5')&45! 0#F! X!(%#/)#&'! $6&%*+=#)'! (;%&+3+*)! $0*$5&)#')-! +*1)*')'! %#! &)B)//)'! 0#F!
0#1&)'!0*10/3+=#)'-!)*!$0'!()!(%#/)#&'!'10B/)'!Y!D')#/)!+*(+$01+%*!04)$!#*!')&4+$)!,5(+$0/!&)*(#!+,.%&10*1E9!
:0!G%,,+''+%*!()!/0!1&0*'.0&)*$)!.%'+1+%**)!/)!8)*10*A/!(;0$1+%*!.&%/%*35)!)*!()#F+2,)!+*1)*1+%*!(0*'!/)!
1&0+1),)*1!()'!(%#/)#&'!$0*$5&)#')'!D04+'!(#!Tb!(5$),B&)!\UTUE9!!
Z&0*j%+')!L0&0,B#&#!
I')&#'!*0$**%1&,5%=%+$)1'!J!D>3$#&'(')&!*'!3E$#($1,+,=%'!J!KL3%&$+!M'++'=#%)2!IKN!*'!O,#*'$-;!
PPQRS!O,#*'$-;!1'*';!!!
!!TTTC3E$#($1,+,=%'C-@?,#*'$-;UC6#!